IEQ Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Buy |
4,539
+170
| +4% | +$14.1K | ﹤0.01% | 1293 |
|
|
2025
Q1 | $354K | Sell |
4,369
-222
| -5% | -$18K | ﹤0.01% | 1122 |
|
|
2024
Q4 | $414K | Sell |
4,591
-389
| -8% | -$35K | ﹤0.01% | 911 |
|
|
2024
Q3 | $492K | Buy |
4,980
+1
| +0% | +$99 | 0.01% | 754 |
|
|
2024
Q2 | $462K | Sell |
4,979
-3,471
| -41% | -$322K | 0.01% | 684 |
|
|
2024
Q1 | $802K | Buy |
8,450
+2,559
| +43% | +$243K | 0.01% | 508 |
|
|
2023
Q4 | $526K | Sell |
5,891
-94
| -2% | -$8.39K | 0.01% | 567 |
|
|
2023
Q3 | $437K | Sell |
5,985
-81
| -1% | -$5.91K | 0.01% | 608 |
|
|
2023
Q2 | $505K | Sell |
6,066
-732
| -11% | -$60.9K | 0.01% | 542 |
|
|
2023
Q1 | $518K | Buy |
6,798
+593
| +10% | +$45.2K | 0.01% | 555 |
|
|
2022
Q4 | $515K | Sell |
6,205
-31,149
| -83% | -$2.59M | 0.01% | 508 |
|
|
2022
Q3 | $2.96M | Buy |
37,354
+31,956
| +592% | +$2.53M | 0.08% | 173 |
|
|
2022
Q2 | $401K | Sell |
5,398
-262
| -5% | -$19.5K | 0.01% | 526 |
|
|
2022
Q1 | $509K | Hold |
5,660
| – | – | 0.01% | 497 |
|
|
2021
Q4 | $634K | Sell |
5,660
-6,652
| -54% | -$745K | 0.01% | 405 |
|
|
2021
Q3 | $1.55M | Sell |
12,312
-190
| -2% | -$23.9K | 0.04% | 223 |
|
|
2021
Q2 | $1.69M | Buy |
12,502
+10,103
| +421% | +$1.37M | 0.05% | 193 |
|
|
2021
Q1 | $325K | Buy |
+2,399
| New | +$325K | 0.01% | 353 |
|
|
2020
Q4 | – | Sell |
-11,893
| Closed | -$1.33M | – | 396 |
|
|
2020
Q3 | $1.33M | Buy |
+11,893
| New | +$1.33M | 0.07% | 147 |
|